(1999) 암 동서의 결합치료 1권, 원광대학교 출판국

(2000) 百合固金湯加味方의 抗腫瘍 效果에 關한 硏究, 圓光大學校 博士學位論文

李竝求, (2000) 八珍湯合化積丸과 Adriamycin의 병용처리시 나타나는 synergistic 抗腫瘍 效果에 關한 硏究, 圓光大學校 博士學位論文

金成鎭 , (1999) 八珍湯合化積丸의 抗腫瘍 效果에 關한 硏究, 圓光大學校 碩士學位論文

姜泰熙, (2001) Cisplatin을 처리한 腦細胞에서 補血免疫丹의 細胞防禦效果,

魯勳政, (1999) 白花蛇舌草 메탄올 抽出物의 抗腫瘍效果 및 抗癌 機轉에 關한 硏究,

張宗岐, (1995) 臨床腫瘤綜合治療大全 第1版,, 奧林匹克出版社

Friesen C, (1999) Cytotoxic drugs and the CD95 pathway,

Wiley SR, , (1995) Identification and characterization of a new member of the TNF family that induces apoptosis,

Mariani SM, (1997) Interleukin 1 beta-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells,

최승훈, (1995) 東醫腫瘍學, , 杏林出版

성현제 외, (1997) 암치료에 있어서 체질과 항암효과에 관한 한의학적 연구,

白垠基, (2002) 인간 간암세포주 HepG2에서 八珍抗癌丹과 Adriamycin의 병용처리에 의한 抗腫瘍 效果,

辛民敎, (1997) 原色臨床本草學, 南山堂

Sun HD, (1992) Ai-Lin I treated 32 cases of acute promyelocytic leukemia,

Akao Y, , (1999) Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase-3 in vitro,

Boonchai W,, (2000) Expression of p53 in arsenic-related and sporadic basal cell carcinoma,

高忠顯 外, (1997) 現代腫瘤診斷治療學, 科學技術文獻出版社

Desagher S,, (2000) Mitochondria as the central control point of apoptosis,

Elledge RM, (1993) The role and prognostic significance of p53 gene alterations in breast cancer,

Oehm A, (1992) Purification and molecular cloning of the APO-1 cell surface antigen a member of the tumor necrosis factor/nerve growth factor receptor superfamily Sequence identity with the Fas antigen,

Enari M, , (1996) Sequential activation of ICE-like and CPP32-like protease during Fas-mediated apoptosis,

Leverkus M,, (1997) Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes, Yaar M

Nimmanapalli R,, (2001) Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels,

Nagane M, , (2000) Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo,

Nagane M,, (2000) Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo,